Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Nilotinib for GIST
NCT01270893Phase 2Withdrawn
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jan 2011
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of nilotinib in gastrointestinal stromal tumor (GIST), sponsored by University of Texas MD Anderson Cancer Center. Planned start Jan 2011; status: withdrawn.
02
Drugs
nilotinib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT01270893.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01270893.